Mayo Clinic Study Proves Robotic Bronchoscopy Boosts Early Lung Cancer Detection

A new five-year study by the Mayo Clinic confirms the effectiveness of robotic-assisted bronchoscopy in diagnosing lung cancer. The technology, which combines precision robotics with real-time imaging, is now used in over 200 medical centres worldwide. Researchers found it significantly improves early detection while keeping complications low. The study focused on shape-sensing robotic bronchoscopy, a minimally invasive method for examining lung lesions. Clinicians used the system to navigate complex airways and sample multiple nodules in both lungs with high accuracy. The technology's sensitivity in detecting malignant growths reached 85%, while its overall diagnostic accuracy stood at nearly 77%.

Of the lesions sampled, 56% were confirmed malignant, 21% were benign, and 23% remained nondiagnostic under strict criteria. The procedure's safety was also notable, with complications occurring in just 2.8% of cases. Integration with endobronchial ultrasound (EBUS) and cone-beam CT scans further improved staging precision and reduced sampling errors.

Lung cancer remains the deadliest form of cancer, yet early detection dramatically improves survival rates. Localised cases have a 67% five-year survival rate, compared to just 12% once the disease spreads. With around 1.6 million suspicious lung nodules detected annually in US screening programs, the need for reliable diagnostic tools is urgent.

Beyond diagnosis, robotic bronchoscopy platforms are now being paired with treatments like pulsed electric field ablation (PEF). This non-thermal approach allows for minimally invasive therapy, expanding the system's role in patient care. The Mayo Clinic's findings reinforce robotic bronchoscopy as a safe and precise tool for lung cancer diagnosis. Its adoption across more than 200 global centres since 2019 highlights its growing importance in early detection. With continued advancements, the technology is also set to play a larger role in minimally invasive treatments.